User profiles for Fl�vio Reis

Fl�vio Reis

Medicine Faculty, Coimbra University
Verified email at fmed.uc.pt
Cited by 8612

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients

…, P Rocha-Pereira, S Rocha, F Reis…�- Acta�…, 2009 - karger.com
Recently, a complex regulatory network that governs iron traffic has emerged, and points to
hepcidin as a major evolutionary conserved regulator of iron distribution [1, 2]. This small …

[HTML][HTML] Dexmedetomidine: current role in anesthesia and intensive care

J Afonso, F Reis�- Revista brasileira de anestesiologia, 2012 - SciELO Brasil
Afonso J, Reis F–Dexmedetomidine: Current Role in Anesthesia and Intensive Care.
Background and objectives: To update and review the application of dexmedetomidine in …

[HTML][HTML] Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties

…, S Nunes, F Teixeira, F Reis�- Cardiovascular diabetology, 2011 - Springer
Diabetes mellitus has emerged as one of the main alarms to human health in the 21st
century. Pronounced changes in the human environment, behavior and lifestyle have …

[HTML][HTML] Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency

…, A Gupta, M Rosaria Lauro, C Carbone, F Reis…�- Nutrients, 2019 - mdpi.com
The human intestine contains an intricate ecological community of dwelling bacteria, referred
as gut microbiota (GM), which plays a pivotal role in host homeostasis. Multiple factors …

Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)

…, A Melo, S Nunes, F Teixeira, F Reis�- Mediators of�…, 2010 - Wiley Online Library
The purpose of this paper is to evaluate the chronic effect of sitagliptin on metabolic profile,
inflammation, and redox status in the Zucker Diabetic Fatty (ZDF) rat, an animal model of …

Diabetic nephropathy amelioration by a low‐dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat)

…, F Teixeira, F Reis�- Journal of Diabetes�…, 2011 - Wiley Online Library
This study was performed to assess the effect of chronic low‐dose sitagliptin, a dipeptidyl
peptidase 4 inhibitor, on metabolic profile and on renal lesions aggravation in a rat model of …

Regular physical exercise as a strategy to improve antioxidant and anti‐inflammatory status: Benefits in type 2 diabetes mellitus

…, J Oliveira, J P�scoa Pinheiro, F Reis�- Oxidative medicine�…, 2012 - Wiley Online Library
Over the last 30 years the combination of both a sedentary lifestyle and excessive food
availability has led to a significant increase in the prevalence of obesity and aggravation of rates …

Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals

…, F Teixeira, C Fontes-Ribeiro, F Reis…�- Mediators of�…, 2014 - Wiley Online Library
This study aimed to evaluate the efficacy of sitagliptin, a dipeptidyl peptidase IV (DPP‐IV)
inhibitor, in preventing the deleterious effects of diabetes on the kidney in an animal model of …

[HTML][HTML] Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy

R Fernandes, SD Viana, S Nunes, F Reis�- Biochimica Et Biophysica Acta�…, 2019 - Elsevier
The increased prevalence of type 2 diabetes mellitus (T2DM) and life expectancy of diabetic
patients fosters the worldwide prevalence of retinopathy and nephropathy, two major …

The place of dipeptidyl peptidase‐4 inhibitors in type 2 diabetes therapeutics: A “me too” or “the special one” antidiabetic class?

…, F Teixeira, R Fernandes, F Reis�- Journal of diabetes�…, 2015 - Wiley Online Library
Incretin‐based therapies, the most recent therapeutic options for type 2 diabetes mellitus (T2DM)
management, can modify various elements of the disease, including hypersecretion of …